ColdFight 360°
ColdFight 360°
Cold-EEZE ProductsCold or Flu?Cold-EEZE Clinical InfoColdcastReal Cold-EEZE StoriesContact Cold-EEZECommon Cold Wellness Information
Is it a Cold or the Flu? Find out now. Where to buy Cold-EEZE Coldcast Is it the Cold or the Flu
Ask the Pharmacist

Suzie Cohen

Pharmacist
View Bio

Q How does Cold-EEZEŽ reduce the duration of my cold?
A Read Suzie´s Answer
Cold-EEZE Latest Information
The results of an independent study, published in the November/December issue of the American Journal of Therapeutics, reinforce the effectiveness of COLD-EEZE®, the nation's leading pharmacist recommended over-the-counter zinc cold remedy. Study findings showed that, when taken daily, COLD-EEZE® patented Zinc Gluconate Glycine formula statistically lessened the number of colds study participants experienced per year, reducing the incidence from 62% to 28%.

Adolescent Study

These findings were the result of an independent analysis of three years of clinical data at the Heritage School facility in Provo, Utah. The study also found that, when COLD-EEZEŽ was taken as a first-line treatment for the common cold, it statistically reduced the use of antibiotics for respiratory illnesses by 92%. Additionally, the study findings reinforce the original clinical trials, showing that COLD-EEZEŽ reduced the median duration of the common cold by approximately 4 days from 10 to 6 days.

Synergy Research Inc., an independent research organization, conducted the retrospective study comprised of more than 170,000 patient days on a student population of 378 adolescents ranging in age from 12 to 18 years. The average length of stay at Heritage School is 14 months.

The Heritage School introduced COLD-EEZEŽ lozenges to aid in the relief of the common cold in response to the high incidence of colds in 1999. COLD-EEZEŽ was administered symptomatically to treat common cold signs and symptoms in September 1999 and became standard practice at the facility in December 2000. Between December 2000 and May 2001, one dose of COLD-EEZEŽ was administered daily to the Heritage School students. Medical statistics then showed a decrease in cold episodes and the findings were reported to The Quigley Corporation.

The Heritage School Study
Started September 1999 - Ended August 2001
School Aged Resident Population aged 12-18
378 patients were evaluated
Study peer reviewed and published in
The American Journal of Theraputics,
vol. 9, no. 6 November 2002

Note: One (1) COLD-EEZEŽ lozenge provides 110% of the US RDA for zinc. Dissolving One (1) lozenge per day for an extended period of time poses little health risk. As with all medical treatments, please consult your medical practitioner prior to using COLD-EEZEŽ daily. For more safety information on COLD-EEZEŽ, click here.

Home |Products | Cold or Flu? | Coldcast | Clinical Info | Real COLD-EEZE® Stories |
Contact Us
| Wellness | Privacy Policy | Legal Notice
Quigley Pharmaceuticals, The Nature of Human Health
Copyright © 2006 The Quigley Corporation All rights reserved.